Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 4Completed 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 11Gastrointestinal 6Genitourinary 5Sarcoma 4CNS 4Breast 4Lymphoid 3Head & Neck 3Other hematologic neoplasm 2Myeloid 2Endocrine 2Dermatologic 2Plasma cell 1Other neoplasm 1Gynecologic 1Classical hematology 1

Conditions

Osteoporosis 1Multiple Endocrine Neoplasia Type 1 1Adrenal Gland Neoplasms 1

Interventions

Everolimus 32Octreotide 15Cisplatin 14pasireotide 13Sunitinib 13Temozolomide 11pembrolizumab 10Etoposide 10Doxorubicin 10lanreotide 9Magnetic Resonance Spectroscopy 9Bevacizumab 9lutetium Lu 177 dotatate 8gallium Ga 68 dotatate 8Sorafenib 8Paclitaxel 83-Iodobenzylguanidine 8lenvatinib 7pazopanib 6Radiotherapy 6Positron Emission Tomography Computed Tomography 6surufatinib 5cabozantinib 5avelumab 5Thyrotropin Alfa 5Surgical Procedures, Operative 5Radiosurgery 5Nivolumab 5Mitotane 5Irinotecan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × X-Rays × Endocrine × Clear all
NCT00591643 2015-12-28

Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
93 enrolled
Endocrine

Adrenal Gland Neoplasms

NCT01250314 2012-07-03

OSTEHOM

Assistance Publique - Hôpitaux de Paris

Phase NA Completed
79 enrolled
Endocrine

Osteoporosis, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡